NL175910B - Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen. - Google Patents

Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.

Info

Publication number
NL175910B
NL175910B NLAANVRAGE7308876,A NL7308876A NL175910B NL 175910 B NL175910 B NL 175910B NL 7308876 A NL7308876 A NL 7308876A NL 175910 B NL175910 B NL 175910B
Authority
NL
Netherlands
Prior art keywords
prevented
prevared
naftyl
antipyretic
inflammatory
Prior art date
Application number
NLAANVRAGE7308876,A
Other languages
English (en)
Other versions
NL175910C (nl
NL7308876A (nl
Original Assignee
Syntex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Corp filed Critical Syntex Corp
Publication of NL7308876A publication Critical patent/NL7308876A/xx
Publication of NL175910B publication Critical patent/NL175910B/nl
Application granted granted Critical
Publication of NL175910C publication Critical patent/NL175910C/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/14Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NLAANVRAGE7308876,A 1972-06-27 1973-06-26 Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen. NL175910C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26664072A 1972-06-27 1972-06-27

Publications (3)

Publication Number Publication Date
NL7308876A NL7308876A (nl) 1974-01-02
NL175910B true NL175910B (nl) 1984-08-16
NL175910C NL175910C (nl) 1985-01-16

Family

ID=23015387

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7308876,A NL175910C (nl) 1972-06-27 1973-06-26 Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.

Country Status (13)

Country Link
JP (1) JPS5438097B2 (nl)
AT (1) AT323145B (nl)
AU (1) AU472375B2 (nl)
BE (1) BE801440A (nl)
CA (1) CA1012159A (nl)
CH (1) CH581605A5 (nl)
DE (1) DE2331665C2 (nl)
ES (1) ES416311A1 (nl)
FR (1) FR2190451B1 (nl)
GB (1) GB1377316A (nl)
IL (1) IL42472A (nl)
NL (1) NL175910C (nl)
ZA (1) ZA733992B (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1508988A (en) * 1987-04-27 1988-10-27 Syntex Pharmaceuticals International Ltd. Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs
KR101366296B1 (ko) * 2012-03-07 2014-02-21 주식회사 포스코 내화재 축조 방법
JP6290947B2 (ja) * 2016-02-05 2018-03-07 テックフィールズ バイオケム カンパニー リミテッド 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1406509A (fr) * 1963-05-02 1965-07-23 Parke Davis & Co Nouveaux composés naphtaléniques et procédé pour leur préparation
ZA701191B (en) * 1969-03-24 1971-09-29 Syntex Corp 2-(6-substituted-2'-naphthyl)acetic acid esters and process for producing same

Also Published As

Publication number Publication date
DE2331665A1 (de) 1974-01-17
FR2190451B1 (nl) 1976-12-31
CA1012159A (en) 1977-06-14
NL175910C (nl) 1985-01-16
JPS504053A (nl) 1975-01-16
IL42472A0 (en) 1973-08-29
AT323145B (de) 1975-06-25
CH581605A5 (nl) 1976-11-15
JPS5438097B2 (nl) 1979-11-19
IL42472A (en) 1977-01-31
NL7308876A (nl) 1974-01-02
ES416311A1 (es) 1976-05-16
AU5690373A (en) 1974-12-19
DE2331665C2 (de) 1983-04-21
AU472375B2 (en) 1976-05-20
ZA733992B (en) 1975-01-29
FR2190451A1 (nl) 1974-02-01
BE801440A (fr) 1973-12-26
GB1377316A (en) 1974-12-11

Similar Documents

Publication Publication Date Title
NL176264C (nl) Werkwijze voor de bereiding van maleinezuuranhydride.
NL185621B (nl) Werkwijze voor de bereiding van maleinezuuranhydride.
NL183183C (nl) Werkwijze voor de bereiding van polyethyleenpolyaminen.
NL157007B (nl) Werkwijze voor de bereiding van dialkylcarbonaten.
NL177117C (nl) Werkwijze voor de bereiding van 2-(3-pyridyl)-thiazolen.
NL7515129A (nl) Werkwijze voor het bereiden van benzoezuren en derivaten daarvan.
NL7605540A (nl) Werkwijze voor de bereiding van melkzuur.
NL168820B (nl) Werkwijze voor het bereiden van 2-(6-methoxy-2-naftyl)- -propionzuur en werkwijze ter bereiding of vervaar- diging van een farmaceutisch preparaat op basis van 2-(6-methoxy-2-naftyl)-propionzuur.
NL7605173A (nl) Werkwijze voor de bereiding van 2-(2,2-dihalo- geenvinyl)-3,3-dimethylcyclopropaancarbonzure esters.
NL175910C (nl) Werkwijze voor het bereiden van anti-inflammatoir, antipyretisch en/of analgetisch werkzame esters van 2-(6-methoxy-2-naftyl)-propionzuur, werkwijze ter bereiding van farmaceutische preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
SE384852B (sv) Forfarande for framstellning av 2-(6-metoxi-2-naftyl) propionsyra
NL7704072A (nl) Werkwijze voor de bereiding van m-fenoxybenzyl- -esters.
NL7604330A (nl) Werkwijze voor de bereiding van 8-azaprostaan- zuurderivaten.
NL7708394A (nl) Werkwijze voor de bereiding van esters.
NL184614C (nl) Werkwijze voor de bereiding van propionzuur en/of propionzuuranhydride.
NL162050C (nl) Werkwijze voor de continue bereiding van zuurstofhoudende verbindingen.
NL7704074A (nl) Werkwijze voor de bereiding van m-fenoxybenzyl- -esters.
NL7704073A (nl) Werkwijze voor de bereiding van m-fenoxybenzyl- -esters.
NL7509078A (nl) Werkwijze voor de bereiding van prostaanzuur- derivaten.
NL180506C (nl) Werkwijze voor de bereiding van carbonzure esters.
NL7411148A (nl) Werkwijze voor de bereiding van d(-)-penicill-a- mine en zouten ervan.
NL7500549A (nl) Werkwijze voor de bereiding van 2-(1-cyclo- hexenyl)-cyclohexanon.
NL155255B (nl) Werkwijze voor de bereiding van 2-(2-amino-5-broombenzoyl) pyridine.
NL7608485A (nl) Werkwijze voor de bereiding van mono- of di- -onverzadigde spirovetivonderivaten.
BE807693A (nl) Werkwijze voor de bereiding van 3-mono-alkyl-en 3,6-dialkyl-resorcylzuuresters

Legal Events

Date Code Title Description
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee
V1 Lapsed because of non-payment of the annual fee